No official vote is planned, and no specific vaccine products will be discussed
Cardiac Complications Up After SARS-CoV-2 Infection Versus Vaccines
Incidence of cardiac outcomes after mRNA COVID-19 vaccination highest in males aged 12 to 17 years, but risk 1.8 to 5.6 times higher after infection
Vaccination Offers Extra Protection After SARS-CoV-2 Infection
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination
COVID-19 Vaccination Early in Pregnancy Not Linked to Fetal Anomalies
Vaccination within teratogenic window not linked to presence of congenital anomalies identified on ultrasonography
BNT162b2 Prevents Critical COVID-19 in Children and Adolescents
During omicron-predominant period, effectiveness of two doses against hospitalization 68 percent for children, 40 percent for adolescents
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 28 to April 1, 2022. …
SARS-CoV-2 Vaccination Seems Safe After MIS-C
No major adverse events seen among 15 children with MIS-C who were subsequently vaccinated against SARS-CoV-2
CDC Supports Second COVID-19 Booster for Americans 50 Years and Older
Echoing the FDA, the CDC also supported a second booster for ‘certain immune-compromised individuals’
Booster Strategies After Janssen Shot Increased Protection Against Omicron
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses
COVID-19 Vaccination Not Linked to Peripartum Adverse Outcomes
Large population-based cohort of more than 22,000 women shows no increased risks with vaccination during pregnancy